Valuation (3%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -14.15 | N/A |
PEG Ratio (TTM) | -1.23 | N/A |
P/S Ratio (TTM) | 506.97 | N/A |
P/B Ratio (TTM) | 27.58 | N/A |
P/FCF Ratio (TTM) | -28.42 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -27.85% | N/A |
ROE (TTM) | -29.56% | N/A |
Net Profit Margin (TTM) | -4,065.34% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (2%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -19.76% | N/A | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | 1.15% | N/A | N/A |
Cash Flow | -3.44% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.02 | N/A |
Quick Ratio (TTM) | 0.02 | N/A |
D/E Ratio (TTM) | 0.52 | N/A |
Interest Coverage (TTM) | -2.40 | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |